Genentech teams with little Novome on IBD research, looking to colonized bacteria after a severe setback

Back at the beginning of 2020, Genentech vet Blake Wise jumped to a startup in the Bay Area called Novome, joining at the same time a syndicate came together to offer a $33 million launch round for a platform biotech out to colonize the gut with engineered strains of bacteria…

...

Click to view original post